85 The enhancing effects of testosterone in exposure treatment for social anxiety disorder Chapter 4 – appendix 2 Completed online screening: 301 Not interested in participating: 48 Not eligible: 19 Speech anxiety not dominant fear: 2 No SAD: 10 Exposure treatment for SAD: 4 Predominant other disorder: 1 Substance/alcohol dependence: 2 Inability to speak Dutch: 1 Randomized: 55 Completed Phone screening (MINI): 122 Not eligible: 79 Predominant other disorder: 2 Substance/alcohol dependence: 6 Somatic illness: 1 Pregnancy: 1 Infertility: 3 Anti psychotic mediation: 3 Contraceptive with crypterone: 4 Age > 45: 10 No speech anxiety: 3 LSAS < 30: 47 Not interested in participating: 51 Lost to phone screening: 44 Allocated to placebo: 28 Allocated to testosterone: 27 Lost to follow-up: 0 Discontinued intervention: 2 1 withdrew after randomisation (prior to exposure) 1 withdrew during exposure session 1 Lost to follow-up: 0 Discontinued intervention: 0 Analyzed: 27 Excluded from analyses: 1 Analyzed: 27 Excluded from analyses: 0 Figure. CONSORT flowchart 4
RkJQdWJsaXNoZXIy MTk4NDMw